Search
Prelude Therapeutics Inc
PRLDAdd to Watchlist
4.910USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
309.10MMarket Cap
LossP/E TTM
Prelude Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
12.14M
73.43%
EPS(YoY)
-1.29
22.93%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its total revenue reached 12.14M, with a year-on-year change of 73.43.
What are the current assets of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its current assets were 105.69M, with a year-on-year change of -22.23.
What are the total assets of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its total assets of Prelude Therapeutics Inc were 141.31M, with a year-on-year change of -19.49.
What are the total liabilities of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its total liabilities of Prelude Therapeutics Inc were 72.68M, with a year-on-year change of 64.97.
What is the total equity of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its total equity of Prelude Therapeutics Inc was 68.64M, with a year-on-year change of -47.79.
What is the net investment of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its net investment of Prelude Therapeutics Inc was 53.46M, with a year-on-year change of -40.73.
What is the net financing of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its net financing of Prelude Therapeutics Inc was 24.82M, with a year-on-year change of 20780.00.
What is the Earnings Per Share (EPS) of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.29, with a year-on-year change of 22.93.
What is the net margin of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its net profit margin was -819.59, with a year-on-year change of 54.89.
What is the Return on Equity (ROE) of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -99.45, with a year-on-year change of -44.10.
What is the Return on Assets (ROA) of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -62.81, with a year-on-year change of -11.91.
What is the operating profit of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its operating profit was -104.57M, with a year-on-year change of 25.16.